Using a mouse model of Alzheimer's disease, the authors demonstrated that boosting the capacity of the sink by administering a form of soluble LRP1, reduces brain amyloid plaque load and improves learning and memory. Here, LRP1 is linked to early-onset autosomal dominant Alzheimer disease.